Literature DB >> 18028874

The binding constant for amyloid Abeta40 peptide interaction with human serum albumin.

Małgorzata Rózga1, Marcin Kłoniecki, Agnieszka Jabłonowska, Michał Dadlez, Wojciech Bal.   

Abstract

Human serum albumin (HSA) is the major carrier of Abeta peptides in blood plasma. 1:1 interaction stoichiometries were established in previous indirect antibody-based studies for both Abeta40 and Abeta42, but corresponding binding constants were not provided. In this study we applied direct titrations of HSA with Abeta40 monitored using circular dichroism spectroscopy and obtained a dissociation constant (K(d)) of 5+/-1 microM for a HSA complex with Abeta40. The interaction resulted in an increase of the alpha-helical contents in the complex, compared to its components, which is quantitatively consistent with the known ability of Abeta40 to adopt a partially alpha-helical conformation in a hydrophobic environment. The relevance of these findings for the role of HSA in Abeta physiology is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028874     DOI: 10.1016/j.bbrc.2007.10.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

Authors:  Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

2.  Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism.

Authors:  Julijana Milojevic; Annie Raditsis; Giuseppe Melacini
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 3.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

4.  Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states.

Authors:  Moustafa Algamal; Rashik Ahmed; Naeimeh Jafari; Bilal Ahsan; Joaquin Ortega; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

5.  Charge dependent retardation of amyloid β aggregation by hydrophilic proteins.

Authors:  Anna Assarsson; Erik Hellstrand; Celia Cabaleiro-Lago; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2014-02-06       Impact factor: 4.418

6.  Fatty Acids Compete with Aβ in Binding to Serum Albumin by Quenching Its Conformational Flexibility.

Authors:  Cong Guo; Huan-Xiang Zhou
Journal:  Biophys J       Date:  2018-12-06       Impact factor: 4.033

7.  Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Susann Cattepoel; Michael Hanenberg; Luka Kulic; Roger M Nitsch
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

8.  Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: implications for Alzheimer disease.

Authors:  Helen F Stanyon; John H Viles
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

9.  Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide.

Authors:  Ekaterina A Litus; Alexey S Kazakov; Evgenia I Deryusheva; Ekaterina L Nemashkalova; Marina P Shevelyova; Aliya A Nazipova; Maria E Permyakova; Elena V Raznikova; Vladimir N Uversky; Sergei E Permyakov
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Soluble aggregates of the amyloid-beta peptide are trapped by serum albumin to enhance amyloid-beta activation of endothelial cells.

Authors:  Adriana A Reyes Barcelo; Francisco J Gonzalez-Velasquez; Melissa A Moss
Journal:  J Biol Eng       Date:  2009-04-27       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.